

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.39189470 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.39189470 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.18137551 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.18137551 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.07989721 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.07903297 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.97299249 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.97299249 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.97299249 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.97299249 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.97299249 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.97299249 |
| 13 | detection of other organism (GO:0098543) | 4.43416007 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.38590355 |
| 15 | detection of bacterium (GO:0016045) | 4.35614809 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.29871589 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.28440352 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 4.10857202 |
| 19 | response to peptidoglycan (GO:0032494) | 4.06374850 |
| 20 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.02337371 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 3.96204603 |
| 22 | negative regulation of interleukin-12 production (GO:0032695) | 3.90675800 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 3.88818195 |
| 24 | B cell receptor signaling pathway (GO:0050853) | 3.85719895 |
| 25 | negative regulation of T cell mediated immunity (GO:0002710) | 3.80615679 |
| 26 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.74705345 |
| 27 | detection of external biotic stimulus (GO:0098581) | 3.73034254 |
| 28 | cellular extravasation (GO:0045123) | 3.68269224 |
| 29 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.61015942 |
| 30 | positive thymic T cell selection (GO:0045059) | 3.50772497 |
| 31 | response to interleukin-15 (GO:0070672) | 3.49182591 |
| 32 | positive regulation of histone deacetylation (GO:0031065) | 3.48888635 |
| 33 | negative T cell selection (GO:0043383) | 3.48478859 |
| 34 | negative thymic T cell selection (GO:0045060) | 3.44832350 |
| 35 | respiratory burst (GO:0045730) | 3.42862063 |
| 36 | detection of molecule of bacterial origin (GO:0032490) | 3.42815773 |
| 37 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.40085474 |
| 38 | daunorubicin metabolic process (GO:0044597) | 3.39068498 |
| 39 | polyketide metabolic process (GO:0030638) | 3.39068498 |
| 40 | doxorubicin metabolic process (GO:0044598) | 3.39068498 |
| 41 | T cell selection (GO:0045058) | 3.38298704 |
| 42 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.37208263 |
| 43 | response to host immune response (GO:0052572) | 3.37208263 |
| 44 | positive T cell selection (GO:0043368) | 3.35606294 |
| 45 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.35475018 |
| 46 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.34056402 |
| 47 | response to muramyl dipeptide (GO:0032495) | 3.33652599 |
| 48 | positive regulation of B cell differentiation (GO:0045579) | 3.30474510 |
| 49 | thymic T cell selection (GO:0045061) | 3.30124628 |
| 50 | neutrophil activation (GO:0042119) | 3.28642996 |
| 51 | sodium ion export (GO:0071436) | 3.26938112 |
| 52 | immunoglobulin mediated immune response (GO:0016064) | 3.24819210 |
| 53 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.21432860 |
| 54 | response to host (GO:0075136) | 3.20549545 |
| 55 | response to host defenses (GO:0052200) | 3.20549545 |
| 56 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.20549545 |
| 57 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.20475959 |
| 58 | detection of biotic stimulus (GO:0009595) | 3.19251770 |
| 59 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.19098007 |
| 60 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.19098007 |
| 61 | regulation of B cell differentiation (GO:0045577) | 3.19088789 |
| 62 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.14040594 |
| 63 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.12490836 |
| 64 | cellular response to interleukin-15 (GO:0071350) | 3.11911789 |
| 65 | mature B cell differentiation (GO:0002335) | 3.09679574 |
| 66 | myeloid cell activation involved in immune response (GO:0002275) | 3.08871743 |
| 67 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.07281482 |
| 68 | granulocyte activation (GO:0036230) | 3.06490910 |
| 69 | leukocyte aggregation (GO:0070486) | 3.06035388 |
| 70 | regulation of tolerance induction (GO:0002643) | 3.05730519 |
| 71 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.05646177 |
| 72 | regulation of mast cell degranulation (GO:0043304) | 3.05339034 |
| 73 | glutamate secretion (GO:0014047) | 3.03234331 |
| 74 | negative regulation of type 2 immune response (GO:0002829) | 3.01676470 |
| 75 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.01255838 |
| 76 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.99418485 |
| 77 | germinal center formation (GO:0002467) | 2.97171527 |
| 78 | positive regulation of catecholamine secretion (GO:0033605) | 2.96257615 |
| 79 | regulation of leukocyte degranulation (GO:0043300) | 2.94544028 |
| 80 | negative regulation of innate immune response (GO:0045824) | 2.91646959 |
| 81 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.91137617 |
| 82 | macrophage activation (GO:0042116) | 2.90716642 |
| 83 | regulation of ARF protein signal transduction (GO:0032012) | 2.87560291 |
| 84 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.85609663 |
| 85 | NIK/NF-kappaB signaling (GO:0038061) | 2.84582117 |
| 86 | microglial cell activation (GO:0001774) | 2.83268444 |
| 87 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.82743539 |
| 88 | neutrophil mediated immunity (GO:0002446) | 2.82716456 |
| 89 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.81756181 |
| 90 | negative regulation of interleukin-6 production (GO:0032715) | 2.80060893 |
| 91 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.79787178 |
| 92 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.79744693 |
| 93 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.78939463 |
| 94 | regulation of regulatory T cell differentiation (GO:0045589) | 2.77370879 |
| 95 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.77238557 |
| 96 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.76846076 |
| 97 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.76552334 |
| 98 | regulation of regulated secretory pathway (GO:1903305) | 2.74958298 |
| 99 | synaptic vesicle maturation (GO:0016188) | 2.74872636 |
| 100 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.74075547 |
| 101 | positive regulation of mast cell activation (GO:0033005) | 2.73697993 |
| 102 | positive regulation of Rap GTPase activity (GO:0032854) | 2.73372822 |
| 103 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.72609847 |
| 104 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.72609847 |
| 105 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.71860553 |
| 106 | interferon-gamma secretion (GO:0072643) | 2.70873890 |
| 107 | adaptation of signaling pathway (GO:0023058) | 2.69235174 |
| 108 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.68456981 |
| 109 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.68207029 |
| 110 | T cell migration (GO:0072678) | 2.64000779 |
| 111 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.62668908 |
| 112 | regulation of Rap GTPase activity (GO:0032317) | 2.59420790 |
| 113 | mature B cell differentiation involved in immune response (GO:0002313) | 2.57356641 |
| 114 | T cell costimulation (GO:0031295) | 2.49307680 |
| 115 | interferon-gamma production (GO:0032609) | 2.48937351 |
| 116 | heparin biosynthetic process (GO:0030210) | 2.48829043 |
| 117 | heparin metabolic process (GO:0030202) | 2.48829043 |
| 118 | lymphocyte costimulation (GO:0031294) | 2.48330206 |
| 119 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.48273047 |
| 120 | T cell homeostasis (GO:0043029) | 2.47713428 |
| 121 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.46128096 |
| 122 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.45905365 |
| 123 | natural killer cell differentiation (GO:0001779) | 2.44811753 |
| 124 | regulation of ARF GTPase activity (GO:0032312) | 2.42913731 |
| 125 | regulation of T cell tolerance induction (GO:0002664) | 2.42710256 |
| 126 | cellular potassium ion homeostasis (GO:0030007) | 2.41243010 |
| 127 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.40483893 |
| 128 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.38880809 |
| 129 | response to type I interferon (GO:0034340) | 2.38394205 |
| 130 | positive regulation of granulocyte differentiation (GO:0030854) | 2.36963712 |
| 131 | suckling behavior (GO:0001967) | 2.34968684 |
| 132 | T cell receptor signaling pathway (GO:0050852) | 2.34707012 |
| 133 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.33837208 |
| 134 | Peyers patch development (GO:0048541) | 2.32846899 |
| 135 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.32846899 |
| 136 | positive regulation of protein deacetylation (GO:0090312) | 2.31007287 |
| 137 | activated T cell proliferation (GO:0050798) | 2.29871058 |
| 138 | type I interferon signaling pathway (GO:0060337) | 2.29133860 |
| 139 | cellular response to type I interferon (GO:0071357) | 2.29133860 |
| 140 | protein localization to endosome (GO:0036010) | 2.26334192 |
| 141 | locomotory exploration behavior (GO:0035641) | 2.26258916 |
| 142 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.26013620 |
| 143 | myeloid dendritic cell differentiation (GO:0043011) | 2.23956770 |
| 144 | regulation of response to interferon-gamma (GO:0060330) | 2.21633704 |
| 145 | nerve growth factor signaling pathway (GO:0038180) | 2.21316277 |
| 146 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.20633796 |
| 147 | lymphocyte homeostasis (GO:0002260) | 2.19803867 |
| 148 | defense response to protozoan (GO:0042832) | 2.19557862 |
| 149 | serine transport (GO:0032329) | 2.19048368 |
| 150 | mast cell degranulation (GO:0043303) | 2.18576609 |
| 151 | mast cell activation involved in immune response (GO:0002279) | 2.18576609 |
| 152 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.18501111 |
| 153 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.16772024 |
| 154 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.16468061 |
| 155 | mast cell activation (GO:0045576) | 2.16378157 |
| 156 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.16244015 |
| 157 | membrane depolarization during action potential (GO:0086010) | 2.13622016 |
| 158 | response to protozoan (GO:0001562) | 2.12556963 |
| 159 | tolerance induction (GO:0002507) | 2.12253295 |
| 160 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.11620959 |
| 161 | myeloid dendritic cell activation (GO:0001773) | 2.11363615 |
| 162 | cardiac left ventricle morphogenesis (GO:0003214) | 2.10379939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.09949326 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.40838006 |
| 3 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.91180986 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.80719872 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 2.77740545 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.58718219 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.58692496 |
| 8 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.51651190 |
| 9 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.44487957 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.42808376 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.40664144 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.34861399 |
| 13 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.34794354 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.30351417 |
| 15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.28389196 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.27091383 |
| 17 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23857405 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.23384889 |
| 19 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.22253033 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.21115156 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.20106092 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.17238136 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.15420446 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.12123471 |
| 25 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.11220438 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09118997 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.05107002 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.03457333 |
| 29 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.02137186 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94341841 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.92902222 |
| 32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88397416 |
| 33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.83658014 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.83110498 |
| 35 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.81694174 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77214441 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.74036164 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.71891271 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70561300 |
| 40 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.67268025 |
| 41 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.66936363 |
| 42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.62680904 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.61613659 |
| 44 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.57915030 |
| 45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.56581576 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56566153 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.49045687 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.48855608 |
| 49 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.48375154 |
| 50 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.46729253 |
| 51 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46392634 |
| 52 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.40355173 |
| 53 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39744675 |
| 54 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.38413278 |
| 55 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38271511 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.38239414 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.38109359 |
| 58 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37587042 |
| 59 | KDM2B_26808549_Chip-Seq_K562_Human | 1.33076978 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32928863 |
| 61 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30991191 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.29519879 |
| 63 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.28772134 |
| 64 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28241384 |
| 65 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.26868394 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23799935 |
| 67 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23448156 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22468584 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21029729 |
| 70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20664007 |
| 71 | MAF_26560356_Chip-Seq_TH2_Human | 1.20266826 |
| 72 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20134049 |
| 73 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.19183288 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19121001 |
| 75 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.18976446 |
| 76 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.17806592 |
| 77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17408886 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16668745 |
| 79 | P68_20966046_ChIP-Seq_HELA_Human | 1.15181470 |
| 80 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.14450610 |
| 81 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14331565 |
| 82 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14232842 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14224611 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14053027 |
| 85 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13144835 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12039415 |
| 87 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11209527 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09280321 |
| 89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09158577 |
| 90 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.08486708 |
| 91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08373321 |
| 92 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.08327723 |
| 93 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.08125549 |
| 94 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06362751 |
| 95 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06280681 |
| 96 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05543099 |
| 97 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05390860 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05324576 |
| 99 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01792158 |
| 100 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.00718990 |
| 101 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00536469 |
| 102 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.00246610 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00159026 |
| 104 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.99909911 |
| 105 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.99643381 |
| 106 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98404255 |
| 107 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.97980848 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94740396 |
| 109 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93202826 |
| 110 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92008803 |
| 111 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91362750 |
| 112 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90995306 |
| 113 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.90295420 |
| 114 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.88443154 |
| 115 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87897150 |
| 116 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.86939744 |
| 117 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85885577 |
| 118 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.85683976 |
| 119 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.85337820 |
| 120 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84987375 |
| 121 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.84921507 |
| 122 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84550265 |
| 123 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.83860519 |
| 124 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.83409129 |
| 125 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82698120 |
| 126 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.81115360 |
| 127 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.80202185 |
| 128 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78829780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.33430818 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.90296137 |
| 3 | MP0004510_myositis | 2.58846433 |
| 4 | MP0001790_abnormal_immune_system | 2.57371188 |
| 5 | MP0005387_immune_system_phenotype | 2.57371188 |
| 6 | MP0003303_peritoneal_inflammation | 2.54857969 |
| 7 | MP0001800_abnormal_humoral_immune | 2.53025834 |
| 8 | MP0000685_abnormal_immune_system | 2.51011264 |
| 9 | MP0005671_abnormal_response_to | 2.22971130 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.18755970 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.10492841 |
| 12 | MP0001533_abnormal_skeleton_physiology | 2.07582339 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.05162847 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.02147821 |
| 15 | MP0002735_abnormal_chemical_nociception | 2.00258060 |
| 16 | MP0002723_abnormal_immune_serum | 2.00077727 |
| 17 | MP0008260_abnormal_autophagy | 1.96866481 |
| 18 | MP0005310_abnormal_salivary_gland | 1.95035482 |
| 19 | MP0002420_abnormal_adaptive_immunity | 1.93841791 |
| 20 | MP0002736_abnormal_nociception_after | 1.92175313 |
| 21 | MP0001819_abnormal_immune_cell | 1.91764527 |
| 22 | MP0001873_stomach_inflammation | 1.91104475 |
| 23 | MP0004381_abnormal_hair_follicle | 1.90487935 |
| 24 | MP0003436_decreased_susceptibility_to | 1.89565873 |
| 25 | MP0008961_abnormal_basal_metabolism | 1.88215312 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.84822113 |
| 27 | MP0005451_abnormal_body_composition | 1.84691443 |
| 28 | MP0001968_abnormal_touch/_nociception | 1.83344566 |
| 29 | MP0005670_abnormal_white_adipose | 1.81472236 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.77078214 |
| 31 | MP0002398_abnormal_bone_marrow | 1.75769367 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.74559753 |
| 33 | MP0004947_skin_inflammation | 1.72661525 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.68813868 |
| 35 | MP0010234_abnormal_vibrissa_follicle | 1.66804108 |
| 36 | MP0005025_abnormal_response_to | 1.64223051 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.60341384 |
| 38 | MP0000716_abnormal_immune_system | 1.56216712 |
| 39 | MP0009785_altered_susceptibility_to | 1.56088938 |
| 40 | MP0002419_abnormal_innate_immunity | 1.53108287 |
| 41 | MP0002822_catalepsy | 1.52821431 |
| 42 | MP0003866_abnormal_defecation | 1.50340861 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.49560655 |
| 44 | MP0003635_abnormal_synaptic_transmissio | 1.48241805 |
| 45 | MP0004130_abnormal_muscle_cell | 1.40560212 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.40331649 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.38832628 |
| 48 | MP0003075_altered_response_to | 1.37701738 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.34992567 |
| 50 | MP0000604_amyloidosis | 1.34331314 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.33896948 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.33537423 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.32307085 |
| 54 | MP0008874_decreased_physiological_sensi | 1.31690459 |
| 55 | MP0002148_abnormal_hypersensitivity_rea | 1.29439044 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.29056090 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.27960160 |
| 58 | MP0005075_abnormal_melanosome_morpholog | 1.27783358 |
| 59 | MP0008569_lethality_at_weaning | 1.27241154 |
| 60 | MP0002722_abnormal_immune_system | 1.27085837 |
| 61 | MP0002429_abnormal_blood_cell | 1.25277716 |
| 62 | MP0000858_altered_metastatic_potential | 1.25167370 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.24056973 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 1.23784913 |
| 65 | MP0002405_respiratory_system_inflammati | 1.18009711 |
| 66 | MP0002132_abnormal_respiratory_system | 1.17224577 |
| 67 | MP0001851_eye_inflammation | 1.17210028 |
| 68 | MP0002064_seizures | 1.14203999 |
| 69 | MP0002006_tumorigenesis | 1.14094988 |
| 70 | MP0006082_CNS_inflammation | 1.13680607 |
| 71 | MP0002063_abnormal_learning/memory/cond | 1.11831736 |
| 72 | MP0002396_abnormal_hematopoietic_system | 1.11580265 |
| 73 | MP0000703_abnormal_thymus_morphology | 1.10963332 |
| 74 | MP0004858_abnormal_nervous_system | 1.09369855 |
| 75 | MP0008877_abnormal_DNA_methylation | 1.08797096 |
| 76 | MP0003828_pulmonary_edema | 1.08443651 |
| 77 | MP0009278_abnormal_bone_marrow | 1.08046924 |
| 78 | MP0002693_abnormal_pancreas_physiology | 1.07106246 |
| 79 | MP0002572_abnormal_emotion/affect_behav | 1.04673493 |
| 80 | MP0002254_reproductive_system_inflammat | 1.04426117 |
| 81 | MP0005174_abnormal_tail_pigmentation | 1.01908373 |
| 82 | MP0004883_abnormal_blood_vessel | 1.01712174 |
| 83 | MP0003045_fibrosis | 1.00925066 |
| 84 | MP0000003_abnormal_adipose_tissue | 1.00503891 |
| 85 | MP0001765_abnormal_ion_homeostasis | 0.99623279 |
| 86 | MP0003329_amyloid_beta_deposits | 0.99170343 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 0.98525032 |
| 88 | MP0005166_decreased_susceptibility_to | 0.97755025 |
| 89 | MP0008469_abnormal_protein_level | 0.97614281 |
| 90 | MP0009745_abnormal_behavioral_response | 0.96571349 |
| 91 | MP0005390_skeleton_phenotype | 0.96428642 |
| 92 | MP0003705_abnormal_hypodermis_morpholog | 0.95992685 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 0.92975224 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.92930967 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 0.92197638 |
| 96 | MP0002971_abnormal_brown_adipose | 0.89785890 |
| 97 | MP0001986_abnormal_taste_sensitivity | 0.89635067 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.89501204 |
| 99 | MP0001663_abnormal_digestive_system | 0.86669058 |
| 100 | MP0000465_gastrointestinal_hemorrhage | 0.85503443 |
| 101 | MP0002272_abnormal_nervous_system | 0.83164283 |
| 102 | MP0002078_abnormal_glucose_homeostasis | 0.82887950 |
| 103 | MP0000516_abnormal_urinary_system | 0.80893071 |
| 104 | MP0005367_renal/urinary_system_phenotyp | 0.80893071 |
| 105 | MP0005360_urolithiasis | 0.80502514 |
| 106 | MP0000490_abnormal_crypts_of | 0.78831636 |
| 107 | MP0005164_abnormal_response_to | 0.78746621 |
| 108 | MP0003690_abnormal_glial_cell | 0.78629330 |
| 109 | MP0000609_abnormal_liver_physiology | 0.78507265 |
| 110 | MP0001853_heart_inflammation | 0.78174191 |
| 111 | MP0005375_adipose_tissue_phenotype | 0.78145599 |
| 112 | MP0005535_abnormal_body_temperature | 0.77843936 |
| 113 | MP0003724_increased_susceptibility_to | 0.77141188 |
| 114 | MP0001958_emphysema | 0.76914663 |
| 115 | MP0003091_abnormal_cell_migration | 0.75611857 |
| 116 | MP0005334_abnormal_fat_pad | 0.74078786 |
| 117 | MP0002796_impaired_skin_barrier | 0.73391875 |
| 118 | MP0002933_joint_inflammation | 0.73194047 |
| 119 | MP0003448_altered_tumor_morphology | 0.73032681 |
| 120 | MP0003633_abnormal_nervous_system | 0.72658208 |
| 121 | MP0004185_abnormal_adipocyte_glucose | 0.71852139 |
| 122 | MP0003879_abnormal_hair_cell | 0.71693730 |
| 123 | MP0001348_abnormal_lacrimal_gland | 0.70843014 |
| 124 | MP0005076_abnormal_cell_differentiation | 0.70679555 |
| 125 | MP0003453_abnormal_keratinocyte_physiol | 0.70165183 |
| 126 | MP0009840_abnormal_foam_cell | 0.70065997 |
| 127 | MP0003795_abnormal_bone_structure | 0.69803685 |
| 128 | MP0009764_decreased_sensitivity_to | 0.69687269 |
| 129 | MP0009780_abnormal_chondrocyte_physiolo | 0.69358062 |
| 130 | MP0009763_increased_sensitivity_to | 0.63541587 |
| 131 | MP0001849_ear_inflammation | 0.62045693 |
| 132 | MP0004264_abnormal_extraembryonic_tissu | 0.60647511 |
| 133 | MP0000343_altered_response_to | 0.58645591 |
| 134 | MP0005397_hematopoietic_system_phenotyp | 0.57157950 |
| 135 | MP0001545_abnormal_hematopoietic_system | 0.57157950 |
| 136 | MP0000249_abnormal_blood_vessel | 0.55662084 |
| 137 | MP0002009_preneoplasia | 0.55072197 |
| 138 | MP0002332_abnormal_exercise_endurance | 0.52409983 |
| 139 | MP0005319_abnormal_enzyme/_coenzyme | 0.52396149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 5.14835966 |
| 2 | Orchitis (HP:0100796) | 4.88621916 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 4.51871099 |
| 4 | Optic neuritis (HP:0100653) | 4.51871099 |
| 5 | Gastrointestinal infarctions (HP:0005244) | 4.12017100 |
| 6 | Chronic otitis media (HP:0000389) | 3.68669186 |
| 7 | Chronic obstructive pulmonary disease (HP:0006510) | 3.52043321 |
| 8 | Obstructive lung disease (HP:0006536) | 3.52043321 |
| 9 | Encephalitis (HP:0002383) | 3.42356450 |
| 10 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.41438487 |
| 11 | Recurrent viral infections (HP:0004429) | 3.40645634 |
| 12 | Eczematoid dermatitis (HP:0000976) | 3.36176987 |
| 13 | Recurrent fungal infections (HP:0002841) | 3.34364957 |
| 14 | Gastrointestinal inflammation (HP:0004386) | 3.29772164 |
| 15 | Inflammation of the large intestine (HP:0002037) | 3.28724859 |
| 16 | Keratoconjunctivitis sicca (HP:0001097) | 3.25553918 |
| 17 | Agammaglobulinemia (HP:0004432) | 3.24665136 |
| 18 | Colitis (HP:0002583) | 3.17685487 |
| 19 | Frequent falls (HP:0002359) | 3.05918859 |
| 20 | Pulmonary infiltrates (HP:0002113) | 3.03814117 |
| 21 | Keratoconjunctivitis (HP:0001096) | 3.00637167 |
| 22 | Urticaria (HP:0001025) | 3.00335045 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.99431108 |
| 24 | Calf muscle hypertrophy (HP:0008981) | 2.98610974 |
| 25 | Verrucae (HP:0200043) | 2.93760887 |
| 26 | Papilloma (HP:0012740) | 2.93760887 |
| 27 | Hemoptysis (HP:0002105) | 2.93239110 |
| 28 | Cellulitis (HP:0100658) | 2.90935594 |
| 29 | T lymphocytopenia (HP:0005403) | 2.89669911 |
| 30 | Limb-girdle muscle atrophy (HP:0003797) | 2.87169667 |
| 31 | Recurrent abscess formation (HP:0002722) | 2.85994420 |
| 32 | Thyroiditis (HP:0100646) | 2.83642807 |
| 33 | Recurrent bacterial skin infections (HP:0005406) | 2.83513195 |
| 34 | Nasal polyposis (HP:0100582) | 2.78336742 |
| 35 | Recurrent bronchitis (HP:0002837) | 2.77619961 |
| 36 | Abnormality of T cell number (HP:0011839) | 2.76515616 |
| 37 | Panhypogammaglobulinemia (HP:0003139) | 2.76386669 |
| 38 | Increased IgM level (HP:0003496) | 2.73821389 |
| 39 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.71487716 |
| 40 | Abnormality of glycolipid metabolism (HP:0010969) | 2.71487716 |
| 41 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.71487716 |
| 42 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.69382627 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.59769488 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.59769488 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.58238104 |
| 46 | IgM deficiency (HP:0002850) | 2.58035652 |
| 47 | Episodic fever (HP:0001954) | 2.57682629 |
| 48 | Increased IgE level (HP:0003212) | 2.55770727 |
| 49 | Hypochromic anemia (HP:0001931) | 2.54318441 |
| 50 | Prolonged bleeding time (HP:0003010) | 2.53117716 |
| 51 | Peritonitis (HP:0002586) | 2.50174054 |
| 52 | Leukocytosis (HP:0001974) | 2.49872400 |
| 53 | Chronic sinusitis (HP:0011109) | 2.48982564 |
| 54 | Arterial thrombosis (HP:0004420) | 2.48203977 |
| 55 | Mediastinal lymphadenopathy (HP:0100721) | 2.47142440 |
| 56 | Abnormality of the nasal mucosa (HP:0000433) | 2.42736674 |
| 57 | Papilledema (HP:0001085) | 2.41677538 |
| 58 | Impaired social interactions (HP:0000735) | 2.41422154 |
| 59 | Abnormal social behavior (HP:0012433) | 2.41422154 |
| 60 | Autoimmune thrombocytopenia (HP:0001973) | 2.40862198 |
| 61 | Meningitis (HP:0001287) | 2.36268076 |
| 62 | Hypergammaglobulinemia (HP:0010702) | 2.32830495 |
| 63 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.32685005 |
| 64 | Mucopolysacchariduria (HP:0008155) | 2.32685005 |
| 65 | Anorexia (HP:0002039) | 2.32313034 |
| 66 | Granulocytopenia (HP:0001913) | 2.31854634 |
| 67 | Visual hallucinations (HP:0002367) | 2.31587398 |
| 68 | Cheilitis (HP:0100825) | 2.31524678 |
| 69 | Restrictive lung disease (HP:0002091) | 2.31396400 |
| 70 | Supranuclear gaze palsy (HP:0000605) | 2.30172516 |
| 71 | Severe combined immunodeficiency (HP:0004430) | 2.29666455 |
| 72 | Focal motor seizures (HP:0011153) | 2.29351991 |
| 73 | Recurrent skin infections (HP:0001581) | 2.25535702 |
| 74 | Pelvic girdle muscle weakness (HP:0003749) | 2.25406770 |
| 75 | Vacuolated lymphocytes (HP:0001922) | 2.24879349 |
| 76 | Poor eye contact (HP:0000817) | 2.24604400 |
| 77 | Achilles tendon contracture (HP:0001771) | 2.23807578 |
| 78 | Slow saccadic eye movements (HP:0000514) | 2.22728709 |
| 79 | Febrile seizures (HP:0002373) | 2.22593007 |
| 80 | Abnormality of T cells (HP:0002843) | 2.22506218 |
| 81 | Pulmonary embolism (HP:0002204) | 2.22080819 |
| 82 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.20476889 |
| 83 | Hypoventilation (HP:0002791) | 2.18572309 |
| 84 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.18530856 |
| 85 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.18366832 |
| 86 | Gangrene (HP:0100758) | 2.16124062 |
| 87 | Focal seizures (HP:0007359) | 2.15967329 |
| 88 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.14873735 |
| 89 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.14873735 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.14873735 |
| 91 | Hypochromic microcytic anemia (HP:0004840) | 2.14775226 |
| 92 | Impaired platelet aggregation (HP:0003540) | 2.14092599 |
| 93 | Abnormal platelet function (HP:0011869) | 2.14092599 |
| 94 | Acute hepatic failure (HP:0006554) | 2.13517836 |
| 95 | Myoglobinuria (HP:0002913) | 2.13406466 |
| 96 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.12576205 |
| 97 | Abnormality of the endocardium (HP:0004306) | 2.12318775 |
| 98 | Deep palmar crease (HP:0006191) | 2.12232203 |
| 99 | Abnormality of the Achilles tendon (HP:0005109) | 2.11553050 |
| 100 | Abnormality of the peritoneum (HP:0002585) | 2.10469439 |
| 101 | Lymphopenia (HP:0001888) | 2.10410911 |
| 102 | Amyloidosis (HP:0011034) | 2.09680288 |
| 103 | Stomatitis (HP:0010280) | 2.09440912 |
| 104 | Fatigue (HP:0012378) | 2.09392165 |
| 105 | Vasculitis (HP:0002633) | 2.06488103 |
| 106 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.05557482 |
| 107 | Abnormality of the pleura (HP:0002103) | 2.05443083 |
| 108 | Increased cerebral lipofuscin (HP:0011813) | 2.04619243 |
| 109 | Combined immunodeficiency (HP:0005387) | 2.03654512 |
| 110 | Interstitial pulmonary disease (HP:0006530) | 2.03428845 |
| 111 | Gingivitis (HP:0000230) | 2.03069403 |
| 112 | Global brain atrophy (HP:0002283) | 2.02565728 |
| 113 | Abnormality of macrophages (HP:0004311) | 2.01576681 |
| 114 | Loss of speech (HP:0002371) | 2.01109184 |
| 115 | Chronic diarrhea (HP:0002028) | 2.01100181 |
| 116 | Increased serum ferritin (HP:0003281) | 2.00577830 |
| 117 | Acne (HP:0001061) | 2.00229424 |
| 118 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.99455414 |
| 119 | Skin ulcer (HP:0200042) | 1.99438783 |
| 120 | Epistaxis (HP:0000421) | 1.99131603 |
| 121 | Petechiae (HP:0000967) | 1.94528487 |
| 122 | Gingival bleeding (HP:0000225) | 1.93894804 |
| 123 | Chest pain (HP:0100749) | 1.93871070 |
| 124 | Pustule (HP:0200039) | 1.92214766 |
| 125 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.90341845 |
| 126 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.90341845 |
| 127 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.90297578 |
| 128 | Cerebellar dysplasia (HP:0007033) | 1.87583195 |
| 129 | Sepsis (HP:0100806) | 1.86391791 |
| 130 | Spontaneous hematomas (HP:0007420) | 1.86126773 |
| 131 | Emphysema (HP:0002097) | 1.85635149 |
| 132 | Keratitis (HP:0000491) | 1.83569574 |
| 133 | Abnormality of iron homeostasis (HP:0011031) | 1.83089956 |
| 134 | Joint swelling (HP:0001386) | 1.82871905 |
| 135 | Hypoplasia of the thymus (HP:0000778) | 1.82371962 |
| 136 | Abnormality of B cell number (HP:0010975) | 1.82286383 |
| 137 | B lymphocytopenia (HP:0010976) | 1.82286383 |
| 138 | Gastrointestinal stroma tumor (HP:0100723) | 1.82113165 |
| 139 | Abnormality of T cell physiology (HP:0011840) | 1.79913664 |
| 140 | Postural instability (HP:0002172) | 1.77315736 |
| 141 | Macroorchidism (HP:0000053) | 1.76931185 |
| 142 | Epileptic encephalopathy (HP:0200134) | 1.73263823 |
| 143 | Neuronal loss in central nervous system (HP:0002529) | 1.72413396 |
| 144 | Shoulder girdle muscle weakness (HP:0003547) | 1.71397563 |
| 145 | Osteomyelitis (HP:0002754) | 1.71073876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.53574082 |
| 2 | MAP3K13 | 3.21790055 |
| 3 | RIPK4 | 3.19562849 |
| 4 | PRPF4B | 2.95638734 |
| 5 | SIK2 | 2.71663783 |
| 6 | MAP3K9 | 2.65665688 |
| 7 | IRAK4 | 2.46051021 |
| 8 | GRK6 | 2.31410685 |
| 9 | ERN1 | 2.08590905 |
| 10 | TYK2 | 1.94555783 |
| 11 | JAK1 | 1.80962818 |
| 12 | DAPK2 | 1.76836188 |
| 13 | FES | 1.71913559 |
| 14 | SYK | 1.66460949 |
| 15 | KSR2 | 1.63520042 |
| 16 | CAMKK2 | 1.63286678 |
| 17 | NTRK3 | 1.63044952 |
| 18 | ITK | 1.54667411 |
| 19 | MAP3K3 | 1.51034904 |
| 20 | PKN2 | 1.47598749 |
| 21 | HCK | 1.47430424 |
| 22 | BTK | 1.45811152 |
| 23 | TRIB3 | 1.45533951 |
| 24 | MAP3K10 | 1.45390626 |
| 25 | EPHA4 | 1.45201650 |
| 26 | ZAP70 | 1.42070459 |
| 27 | FGFR4 | 1.40634977 |
| 28 | EEF2K | 1.34880840 |
| 29 | MAP3K7 | 1.34800107 |
| 30 | ARAF | 1.31483329 |
| 31 | JAK3 | 1.28104399 |
| 32 | PRKCH | 1.26357184 |
| 33 | MAP3K1 | 1.23831495 |
| 34 | SIK3 | 1.22561708 |
| 35 | CAMKK1 | 1.20295077 |
| 36 | SMG1 | 1.18059201 |
| 37 | TXK | 1.17966461 |
| 38 | TBK1 | 1.17492136 |
| 39 | FGFR3 | 1.16432122 |
| 40 | TEC | 1.15678699 |
| 41 | TAOK3 | 1.15421999 |
| 42 | CAMK1D | 1.12910718 |
| 43 | JAK2 | 1.11911523 |
| 44 | PTK6 | 1.10195514 |
| 45 | RAF1 | 1.09768138 |
| 46 | HIPK2 | 1.09473596 |
| 47 | TNK2 | 1.06704325 |
| 48 | BLK | 1.06417826 |
| 49 | MAP3K2 | 1.05556491 |
| 50 | IRAK3 | 1.03606929 |
| 51 | FGR | 1.02555683 |
| 52 | CAMK1G | 1.00465714 |
| 53 | STK10 | 0.97678883 |
| 54 | MAP3K14 | 0.96945748 |
| 55 | CDC42BPA | 0.92368636 |
| 56 | TAOK1 | 0.91493228 |
| 57 | LYN | 0.90886339 |
| 58 | MAP3K4 | 0.90521237 |
| 59 | KIT | 0.89197295 |
| 60 | LCK | 0.87275361 |
| 61 | CSK | 0.86436867 |
| 62 | CSF1R | 0.85410587 |
| 63 | IKBKE | 0.84879352 |
| 64 | YES1 | 0.84532147 |
| 65 | TGFBR2 | 0.84447577 |
| 66 | IKBKB | 0.84340018 |
| 67 | PDK1 | 0.82035888 |
| 68 | PRKCQ | 0.80766098 |
| 69 | CDK9 | 0.80653205 |
| 70 | DAPK1 | 0.80255696 |
| 71 | RPS6KA2 | 0.78087973 |
| 72 | MAP2K1 | 0.77989062 |
| 73 | STK38 | 0.77897625 |
| 74 | TESK2 | 0.77606622 |
| 75 | RET | 0.74893186 |
| 76 | TAOK2 | 0.73840974 |
| 77 | SIK1 | 0.73015641 |
| 78 | MARK3 | 0.69972042 |
| 79 | MAP3K12 | 0.69714228 |
| 80 | DYRK1B | 0.68930087 |
| 81 | EPHB1 | 0.67344572 |
| 82 | MAPK12 | 0.66797353 |
| 83 | SGK3 | 0.66686729 |
| 84 | MAPK7 | 0.65800923 |
| 85 | IRAK2 | 0.65388475 |
| 86 | CAMK1 | 0.65387222 |
| 87 | MARK2 | 0.65338678 |
| 88 | PRKD2 | 0.65273961 |
| 89 | ALK | 0.63767185 |
| 90 | MAP3K11 | 0.63141337 |
| 91 | MAP2K6 | 0.61831903 |
| 92 | LRRK2 | 0.60792219 |
| 93 | FLT3 | 0.59595257 |
| 94 | MAP2K3 | 0.57186634 |
| 95 | DMPK | 0.57134435 |
| 96 | MATK | 0.56997212 |
| 97 | PDPK1 | 0.56193955 |
| 98 | CDK5 | 0.56156425 |
| 99 | RIPK1 | 0.56101742 |
| 100 | PRKD3 | 0.54089580 |
| 101 | FYN | 0.53668213 |
| 102 | MAP2K2 | 0.51414068 |
| 103 | ABL1 | 0.50625275 |
| 104 | CDK12 | 0.50467242 |
| 105 | NTRK2 | 0.50204766 |
| 106 | STK11 | 0.49487009 |
| 107 | TTN | 0.48719218 |
| 108 | MAP2K4 | 0.47985547 |
| 109 | MAPK4 | 0.47951936 |
| 110 | IRAK1 | 0.47561933 |
| 111 | GRK7 | 0.47239643 |
| 112 | PASK | 0.46578982 |
| 113 | KSR1 | 0.44421007 |
| 114 | RPS6KC1 | 0.44256391 |
| 115 | RPS6KL1 | 0.44256391 |
| 116 | MAPK11 | 0.41899770 |
| 117 | SGK2 | 0.41769136 |
| 118 | BMPR2 | 0.41295809 |
| 119 | ICK | 0.39855367 |
| 120 | CLK1 | 0.39728680 |
| 121 | CHUK | 0.38658535 |
| 122 | MINK1 | 0.38606115 |
| 123 | RPS6KA6 | 0.37279681 |
| 124 | MOS | 0.36615186 |
| 125 | MAP3K5 | 0.36120988 |
| 126 | PTK2B | 0.35593743 |
| 127 | MAPKAPK2 | 0.35247658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.49256392 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.33476188 |
| 3 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.31456083 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.12890924 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.06318484 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.02141451 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 1.95531553 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.95507507 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.80761929 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75393999 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.64851843 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.59932475 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.55317979 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.49151163 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 1.47307874 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.46758298 |
| 17 | Olfactory transduction_Homo sapiens_hsa04740 | 1.45459819 |
| 18 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.44095402 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.43939200 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.40346744 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.33463845 |
| 22 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.32029173 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31721023 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.29772843 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.29616424 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29309451 |
| 27 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28137481 |
| 28 | Hepatitis C_Homo sapiens_hsa05160 | 1.25846477 |
| 29 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.25731560 |
| 30 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.24946601 |
| 31 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.23657061 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.20770043 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.20521149 |
| 34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.18128571 |
| 35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.17095203 |
| 36 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.15387229 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.14917209 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.14794053 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13442936 |
| 40 | Cocaine addiction_Homo sapiens_hsa05030 | 1.13288360 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.12748039 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11964731 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.11937237 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.11911110 |
| 45 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.11252646 |
| 46 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.10577017 |
| 47 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.10294321 |
| 48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.06876685 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06473984 |
| 50 | Nicotine addiction_Homo sapiens_hsa05033 | 1.05705319 |
| 51 | Long-term depression_Homo sapiens_hsa04730 | 1.05118142 |
| 52 | Morphine addiction_Homo sapiens_hsa05032 | 1.05064293 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.04972568 |
| 54 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.03190317 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.02834672 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.01930159 |
| 57 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.01777236 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 1.01446563 |
| 59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.00091717 |
| 60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99520985 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.97430948 |
| 62 | GABAergic synapse_Homo sapiens_hsa04727 | 0.95273448 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.94811437 |
| 64 | Tuberculosis_Homo sapiens_hsa05152 | 0.93458763 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.93281932 |
| 66 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92549385 |
| 67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.92529448 |
| 68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92305109 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91285704 |
| 70 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.90764436 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.90410982 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90074483 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.89583306 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.89348510 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87794725 |
| 76 | Shigellosis_Homo sapiens_hsa05131 | 0.86880163 |
| 77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85954415 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.85126992 |
| 79 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.84332271 |
| 80 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.83534544 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.83081318 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.83063739 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.83017102 |
| 84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.81433482 |
| 85 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.81384226 |
| 86 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.80672429 |
| 87 | Measles_Homo sapiens_hsa05162 | 0.80371543 |
| 88 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79747979 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.78043569 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77579127 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77571275 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.77064822 |
| 93 | Salmonella infection_Homo sapiens_hsa05132 | 0.76983423 |
| 94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76445095 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74670280 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74261121 |
| 97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74215638 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71942493 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69933965 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69448025 |
| 101 | Pertussis_Homo sapiens_hsa05133 | 0.69112424 |
| 102 | Hepatitis B_Homo sapiens_hsa05161 | 0.68726195 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66827524 |
| 104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66399182 |
| 105 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65858512 |
| 106 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.65661285 |
| 107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65591137 |
| 108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64966251 |
| 109 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64872682 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64176737 |
| 111 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61169664 |
| 112 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.61038779 |
| 113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60796310 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59734562 |
| 115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59302460 |
| 116 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.58993165 |
| 117 | ABC transporters_Homo sapiens_hsa02010 | 0.58776751 |
| 118 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58444796 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58400262 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58268096 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57262905 |
| 122 | Influenza A_Homo sapiens_hsa05164 | 0.56884629 |
| 123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55926307 |
| 124 | Apoptosis_Homo sapiens_hsa04210 | 0.55887426 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55840765 |
| 126 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55828175 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55126820 |
| 128 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54808287 |
| 129 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54302148 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53755115 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52978113 |
| 132 | Taste transduction_Homo sapiens_hsa04742 | 0.52575376 |
| 133 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52328640 |
| 134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48833506 |
| 135 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47037518 |
| 136 | Amoebiasis_Homo sapiens_hsa05146 | 0.45659834 |
| 137 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45188168 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44490888 |
| 139 | Bladder cancer_Homo sapiens_hsa05219 | 0.43878360 |
| 140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43598443 |
| 141 | Prostate cancer_Homo sapiens_hsa05215 | 0.43328454 |

